Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
基本信息
- 批准号:9063173
- 负责人:
- 金额:$ 46.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-08-12 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressApolipoprotein EApoptosisCardiacCardiovascular systemCell CycleCell physiologyCessation of lifeCryoultramicrotomyDevelopmentDiseaseEndothelial CellsEndotheliumEventFamily suidaeGene ExpressionHealthHumanIn Situ HybridizationIn Situ Nick-End LabelingIn VitroInflammationInflammatoryLeadLesionMessenger RNAMicroRNAsMolecularMusProcessRNARisk FactorsRoleSclerosisSideStaining methodStainsStressThickTissue EngineeringTissuesValidationWestern BlottingWorkaortic valveaortic valve disordercalcificationdesigndiagnostic biomarkerfeedingin vivoin vivo Modelinhibitor/antagonistinsightinterstitial cellloss of functionmicroCTmigrationmouse modelpre-miRNAshear stresstherapeutic targetwestern diet
项目摘要
DESCRIPTION (provided by applicant): Calcific aortic valve (AV) disease is a major cause of cardiac-related deaths worldwide and is a strong risk factor for additional cardiovascular events. AV disease was originally thought to be a "wear and tear" process but now it is known to be an active inflammatory disease leading to sclerotic and calcific lesions. Further, AV disease occurs preferentially on the fibrosa side whereas the ventricularis side remains relatively healthy. The mechanism by which shear contributes to this disease remains unknown. We hypothesize that disturbed flow conditions are present on the fibrosa side and regulate endothelial gene expression - miRNAs and mRNAs that lead to AV inflammation and calcification. Previously, we have identified shear-responsive miRNAs in human aortic valvular endothelial cells (HAVECs); however, the importance and function of these miRNAs remains unknown. Recently, we have identified side-dependent miRNAs from freshly isolated endothelial- enriched RNA in porcine AVs. From this work, we have identified miR-199a-5p, miR-214, and miR-486-5p as the top three shear- and/or side-dependent miRNAs. We hypothesize that these are mechanosensitive miRNAs in endothelium which leads to AV inflammation and calcification. To address this hypothesis, we propose the following aims. First, we will determine the role of mechanosensitive miRNAs in aortic valve endothelium in vitro and in porcine AVs. Shear- and side-dependent expression of miR-199a-5p, 214, and 486- 5p will be validated in cultured AVECs and freshly isolated, endothelial-enriched RNA from human and porcine AVs using qPCR and in situ hybridization. The role of these miRNAs in shear-sensitive endothelial function, including inflammation, migration, apoptosis, proliferation, and cell cycle will be investigated using gain- r loss-of-function studies. Next, we will determine the role of mechanosensitive miRNAs in aortic valve endothelium ex vivo using porcine AVs. Array studies with validation will be completed in porcine AVs exposed to laminar shear or oscillatory shear stress conditions to identify shear- and side-dependent miRNAs in both endothelial-enriched RNA as well as RNA from the leftover tissue (mainly interstitial cells). Following validation, the levels of the key miRNAs (miR-199a, 214, and 486-5p) will be modulated and assessed for cell function changes pertaining to inflammation and calcification. Finally, we will determine the role of mechanosensitive miRNAs in AV calcification and inflammation in vivo. AV disease will be modeled in vivo using ApoE-/- mice fed a Western diet. Development of inflammation, sclerosis (valve thickness), apoptosis, and calcification will be characterized. This mouse model of AV calcification will be used to validate the selected miRNAs from Aims 1 and 2 in an in vivo setting with the use of LNA inhibitors or miRNA precursors. Identification of these miRNAs will provide insight to molecular mechanisms by which AV disease occurs, offering potential therapeutic targets and diagnostic markers as well as important considerations in designing tissue-engineered valves.
描述(由申请方提供):钙化性主动脉瓣(AV)疾病是全球心脏相关死亡的主要原因,也是其他心血管事件的强风险因素。AV疾病最初被认为是一个“磨损”过程,但现在已知它是一种导致硬化和钙化病变的活动性炎症性疾病。此外,AV疾病优先发生在纤维侧,而心室侧保持相对健康。剪切导致这种疾病的机制仍不清楚。我们假设,干扰的流动条件存在于纤维瘤侧,并调节内皮基因表达-导致AV炎症和钙化的miRNA和mRNA。在此之前,我们已经在人主动脉瓣内皮细胞(HAVEC)中鉴定了剪切反应性miRNA;然而,这些miRNA的重要性和功能仍然未知。最近,我们已经从猪AV中新鲜分离的内皮富集RNA中鉴定了侧依赖性miRNA。从这项工作中,我们已经确定miR-199 a-5 p,miR-214和miR-486- 5 p为前三名剪切和/或侧依赖性miRNA。我们假设这些是内皮细胞中的机械敏感性miRNA,导致AV炎症和钙化。为了解决这一假设,我们提出了以下目标。首先,我们将确定机械敏感性miRNA在体外和猪AV中的主动脉瓣内皮中的作用。将使用qPCR和原位杂交在培养的AVEC和新鲜分离的来自人和猪AV的内皮富集RNA中验证miR-199 a-5 p、214和486- 5 p的剪切和侧向依赖性表达。这些miRNA在剪切敏感性内皮功能中的作用,包括炎症、迁移、凋亡、增殖和细胞周期,将使用功能获得或丧失研究来研究。接下来,我们将使用猪AV体外确定机械敏感性miRNA在主动脉瓣内皮中的作用。将在暴露于层流剪切或振荡剪切应力条件的猪AV中完成验证的阵列研究,以鉴定内皮富集RNA以及来自剩余组织(主要是间质细胞)的RNA中的剪切和侧依赖性miRNA。验证后,将调节关键miRNA(miR-199 a、214和486- 5 p)的水平,并评估与炎症和钙化有关的细胞功能变化。最后,我们将确定机械敏感性miRNA在体内AV钙化和炎症中的作用。AV疾病将使用喂食西方饮食的ApoE-/-小鼠在体内建模。将表征炎症、硬化(瓣膜厚度)、细胞凋亡和钙化的发展。该AV钙化的小鼠模型将用于使用LNA抑制剂或miRNA前体在体内环境中验证来自目的1和2的所选miRNA。这些miRNAs的鉴定将为AV疾病发生的分子机制提供深入了解,提供潜在的治疗靶点和诊断标志物,以及设计组织工程瓣膜的重要考虑因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hanjoong Jo其他文献
Hanjoong Jo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hanjoong Jo', 18)}}的其他基金
Role of CEBPb in flow-dependent endothelial dysfunction and atherosclerosis
CEBPb 在血流依赖性内皮功能障碍和动脉粥样硬化中的作用
- 批准号:
10638650 - 财政年份:2023
- 资助金额:
$ 46.29万 - 项目类别:
HEG1 in endothelial function and atherosclerosis
HEG1在内皮功能和动脉粥样硬化中的作用
- 批准号:
10272942 - 财政年份:2021
- 资助金额:
$ 46.29万 - 项目类别:
HEG1 in endothelial function and atherosclerosis
HEG1在内皮功能和动脉粥样硬化中的作用
- 批准号:
10630328 - 财政年份:2021
- 资助金额:
$ 46.29万 - 项目类别:
Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
- 批准号:
10171094 - 财政年份:2020
- 资助金额:
$ 46.29万 - 项目类别:
Role of flow-sensitive KLK10 in endothelial dysfunction and atherosclerosis
流量敏感的 KLK10 在内皮功能障碍和动脉粥样硬化中的作用
- 批准号:
10210428 - 财政年份:2018
- 资助金额:
$ 46.29万 - 项目类别:
Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
- 批准号:
8563026 - 财政年份:2013
- 资助金额:
$ 46.29万 - 项目类别:
Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
- 批准号:
8720061 - 财政年份:2013
- 资助金额:
$ 46.29万 - 项目类别:
Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
- 批准号:
10510621 - 财政年份:2013
- 资助金额:
$ 46.29万 - 项目类别:
Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
- 批准号:
10321908 - 财政年份:2013
- 资助金额:
$ 46.29万 - 项目类别:
Shear stress, endothelial miRNAs, and AV calcification
剪切应力、内皮 miRNA 和 AV 钙化
- 批准号:
9270596 - 财政年份:2013
- 资助金额:
$ 46.29万 - 项目类别:
相似海外基金
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
- 批准号:
10658408 - 财政年份:2023
- 资助金额:
$ 46.29万 - 项目类别:
A Therapeutic Role for Apolipoprotein-E in the Germ Theory of Alzheimer's Dementia
载脂蛋白-E 在阿尔茨海默氏痴呆病菌理论中的治疗作用
- 批准号:
10601779 - 财政年份:2023
- 资助金额:
$ 46.29万 - 项目类别:
Investigating how apolipoprotein E genotypes modify fatty acid metabolism
研究载脂蛋白 E 基因型如何改变脂肪酸代谢
- 批准号:
RGPIN-2018-06116 - 财政年份:2022
- 资助金额:
$ 46.29万 - 项目类别:
Discovery Grants Program - Individual
Targeting apolipoprotein E for Alzheimer's disease therapy.
靶向载脂蛋白 E 治疗阿尔茨海默病。
- 批准号:
22K06460 - 财政年份:2022
- 资助金额:
$ 46.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10674878 - 财政年份:2022
- 资助金额:
$ 46.29万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 和阿尔茨海默病的免疫代谢
- 批准号:
10388528 - 财政年份:2022
- 资助金额:
$ 46.29万 - 项目类别:
The role of apolipoprotein E in Alzheimer's adaptive immunity
载脂蛋白E在阿尔茨海默病适应性免疫中的作用
- 批准号:
10515592 - 财政年份:2022
- 资助金额:
$ 46.29万 - 项目类别:
Apolipoprotein E and immunometabolism in Alzheimer's disease
载脂蛋白 E 与阿尔茨海默病的免疫代谢
- 批准号:
10644996 - 财政年份:2022
- 资助金额:
$ 46.29万 - 项目类别:
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis
载脂蛋白E糖基化及其在阿尔茨海默病发病机制中的作用
- 批准号:
10601040 - 财政年份:2021
- 资助金额:
$ 46.29万 - 项目类别:
Impact of cysteine modifications of apolipoprotein E on the remnant lipoprotein metabolism
载脂蛋白E半胱氨酸修饰对残余脂蛋白代谢的影响
- 批准号:
21K07310 - 财政年份:2021
- 资助金额:
$ 46.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)